Results 101 to 110 of about 15,040 (247)

FAIRly deferred: Low impact of the individualised risk assessment policy on blood donor deferrals in England

open access: yesTransfusion Medicine, EarlyView.
Abstract Objectives To assess the impact of the individualised risk‐based donor selection guidelines on deferral of blood donors at donation sessions in England. Background From June 2021, the 3‐month deferral for sex between men was replaced by an individualised risk assessment known as FAIR (For the Assessment of Individualised Risk).
Katherine Daly   +3 more
wiley   +1 more source

Êxtase (3,4- Metilenodioximetanfetamina - MDMA): uma abordagem epidemiológica, clínica e toxicológica. [PDF]

open access: yes, 2006
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina. Curso de Medicina.
Frare, Glauco Luis
core  

MDMA-assisted psychotherapy for the treatment of PTSD

open access: yes, 2022
Recent evidence suggests that MDMA-assisted Psychotherapy for the treatment of PTSD might help treatment-resistant patients. Treatment-resistant post-traumatic stress disorder patients do not have many therapeutic options since the currently used ...
Mazor, David
core  

Adaptation of the International Consortium for Health Outcomes Measurement Standard Set for Inflammatory Bowel Disease for Routine Collection in Clinical Practice

open access: yesJCC Plus, Volume 1, Issue 4, July 2026.
ABSTRACT Background and Aims Value‐based healthcare (VBHC) is based on evaluating clinical interventions according to their ability to improve outcomes and costs to finally enhance quality of care. As part of an initiative to introduce VBHC in inflammatory bowel disease (IBD), our project aimed to adapt the International Consortium for Health Outcomes ...
Xavier Calvet   +33 more
wiley   +1 more source

Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats

open access: yes, 2020
The acute effects of the party drug 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) in humans include feelings of love, closeness towards other people and an increased acceptance of others views and feelings.
Callaghan, PD   +3 more
core   +1 more source

Visuospatial working memory impairment in current and previous ecstasy/polydrug users [PDF]

open access: yes, 2011
Objective: Previous research suggests that ecstasy users are impaired in processing visuospatial information. However, for the most part, the deficits observed appear to involve the recall and recognition of complex visual and geometric patterns.
Montgomery, C   +8 more
core   +1 more source

Clinical Challenges in Transition to Adult Care for Young People With Endocrinopathies

open access: yesClinical Endocrinology, Volume 105, Issue 1, Page 14-21, July 2026.
ABSTRACT The complexity of transition of pediatric patients to adult care is well recognized, with a multidisciplinary approach widely agreed to be essential. Despite extensive existing literature in this area, practical guidance as to the management of specific medical aspects and how to address these with patients and families is lacking, with little
Margaret Zacharin, Quynh‐Nhu Nguyen
wiley   +1 more source

MDMA for Treatment of PTSD [poster]

open access: yes, 2023
The purpose of this paper is to show the current success of using MDMA and psychotherapy to treat this devastating disorder ...
Hensley, Melissa
core  

MDMA: Beyond Ecstasy:Report from the State Commission on MDMA

open access: yes
MDMA: Voorbij de extase van de Staatscommissie MDMA. Het is een titel met meerdere interpretaties. Allereerst refereert het aan het effect van MDMA op de gebruiker; aan een roes die eindig is.
Toebes, Brigit   +5 more
core   +2 more sources

Accuracy of Patient‐Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments: Findings From the Emerging Drugs Network of Australia

open access: yesDrug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction New psychoactive substances (NPS) present a unique challenge in clinical, public health and drug‐policy contexts. Continued diversity, unknown potency and often unintentional exposure can limit the accuracy of self‐reported data.
Marjan J. Nijmeijer   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy